细胞活性小分子抑制剂验证SNM1ADNA修复核酶作为癌症标
Marcin Bielinski1, Lucy R Henderson2, Yuliana Yosaatmadja3
1Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford Mansfield Road Oxford OX1 3TA UK christopher.schofield@chem.ox.ac.uk.
研究人员开发了针对SNM1A金属β-乳糖酶折叠核酶的新型抑制剂,这对于DNA修复至关重要. 这些化合物使癌细胞对化疗敏感,突出显示SNM1A是有前途的药物标.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 人类SNM1A-C金属β-乳糖酶 (MBL) 折叠核酶对于DNA损伤修复和端粒维护至关重要.
- 遗传研究强调SNM1A作为增强癌症治疗的潜在治疗点.
研究的目的:
- 为癌症治疗确定和优化SNM1A的抑制剂.
- 为了验证MBL折叠核酶作为药物开发的可处理的目标.
主要方法:
- 高通量查确定了最初的SNM1A抑制剂药.
- 结晶学揭示了与SNM1A活性部位结合的抑制剂.
- 结构-活性关系的优化导致了奎纳素-胺酸抑制剂.
主要成果:
- 优化的抑制剂通过取代水并占据核基位置来结合.
- 细胞测试表明SNM1A抑制剂增强对西斯的敏感性.
- 抑制剂导致了在解决西斯胺诱导的DNA损伤中的缺陷.
结论:
- SNM1A抑制剂有效地使癌细胞对破坏DNA的药物敏感.
- 金属β-乳糖酶折叠核酶被证实是有希望的癌症药物标.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
DNA Helicases
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Intrinsic Apoptotic Pathway
